{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:11:18Z","timestamp":1777619478883,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1124\/molpharm.121.000357","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T20:00:21Z","timestamp":1631217621000},"page":"480-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Construction and Characterization of CRISPR\/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene"],"prefix":"10.1016","volume":"100","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuyang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.121.000357_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13065-018-0372-y","article-title":"Determination of flutamide and two major metabolites using HPLC-DAD and HPTLC methods","volume":"12","author":"Abdelwahab","year":"2018","journal-title":"Chem Cent J"},{"key":"10.1124\/molpharm.121.000357_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/dmd.116.072652","article-title":"Age-dependent absolute abundance of hepatic carboxylesterases (CES1 and CES2) by LC-MS\/MS proteomics: application to PBPK modeling of oseltamivir in vivo pharmacokinetics in infants","volume":"45","author":"Boberg","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1124\/molpharm.121.000357_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389200219666180821094502","article-title":"The impact of carboxylesterases in drug metabolism and pharmacokinetics","volume":"20","author":"Di","year":"2019","journal-title":"Curr Drug Metab"},{"key":"10.1124\/molpharm.121.000357_bib5","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1021\/bi700246n","article-title":"Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun","volume":"46","author":"Fleming","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/molpharm.121.000357_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF00400744","volume":"111","author":"Frank","year":"1986","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1124\/molpharm.121.000357_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abb.2006.01.015","article-title":"Hepatocyte nuclear factor-4alpha plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver","volume":"447","author":"Furihata","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/molpharm.121.000357_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/dmd.115.068957","article-title":"Age-dependent human hepatic carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) postnatal ontogeny","volume":"44","author":"Hines","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00335-010-9284-4","article-title":"Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins","volume":"21","author":"Holmes","year":"2010","journal-title":"Mamm Genome"},{"key":"10.1124\/molpharm.121.000357_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00005-016-0427-5","article-title":"CRISPR\/Cas9 immune system as a tool for genome engineering","volume":"65","author":"Hryhorowicz","year":"2017","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1124\/molpharm.121.000357_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/molpharm.121.000357_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138920010794328904","article-title":"The role of intestinal carboxylesterase in the oral absorption of prodrugs","volume":"11","author":"Imai","year":"2010","journal-title":"Curr Drug Metab"},{"key":"10.1124\/molpharm.121.000357_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1248\/bpb.b17-00880","article-title":"Development of a Caco-2 cell line carrying the human intestine-type CES expression profile as a promising tool for ester-containing drug permeability studies","volume":"41","author":"Ishizaki","year":"2018","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/molpharm.121.000357_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist\u2019s point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1124\/molpharm.121.000357_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","article-title":"Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases","volume":"279","author":"Kamendulis","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.121.000357_bib16","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0969-2126(97)00306-7","article-title":"Crystal structure of carboxylesterase from Pseudomonas fluorescens, an alpha\/beta hydrolase with broad substrate specificity","volume":"5","author":"Kim","year":"1997","journal-title":"Structure"},{"key":"10.1124\/molpharm.121.000357_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1124\/dmd.115.064089","article-title":"Characterization of species differences in tissue diltiazem deacetylation identifies Ces2a as a rat-specific diltiazem deacetylase","volume":"43","author":"Kurokawa","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1124\/molpharm.121.000357_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/molpharm.121.000357_bib20","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.28472","article-title":"Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"10.1124\/molpharm.121.000357_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"key":"10.1124\/molpharm.121.000357_bib22","article-title":"CRISPR-Cas9: a method for establishing rat models of drug metabolism and pharmacokinetics","author":"Lu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/molpharm.121.000357_bib23","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1124\/dmd.105.006163","article-title":"Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites","volume":"33","author":"Ma","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib24","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.apsb.2019.11.007","article-title":"Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR\/Cas9: a novel model for drug transport and hyperbilirubinemia disease","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/molpharm.121.000357_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hep4.1292","article-title":"Intestine-specific overexpression of carboxylesterase 2c protects mice from diet-induced liver steatosis and obesity","volume":"3","author":"Maresch","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1124\/molpharm.121.000357_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1067\/mcp.2002.127396","article-title":"Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype","volume":"72","author":"Molden","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/molpharm.121.000357_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-005-1027-y","article-title":"Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice","volume":"56","author":"Morton","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl 2","key":"10.1124\/molpharm.121.000357_bib28","first-page":"S9","article-title":"Candesartan cilexetil: a review of its preclinical pharmacology","volume":"11","author":"Nishikawa","year":"1997","journal-title":"J Hum Hypertens"},{"key":"10.1124\/molpharm.121.000357_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","article-title":"A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development","volume":"30","author":"Oda","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/molpharm.121.000357_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/dmd.113.054551","article-title":"Distinct patterns of aging effects on the expression and activity of carboxylesterases in rat liver and intestine","volume":"42","author":"Ohura","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.celrep.2016.12.070","article-title":"Human carboxylesterase 2 reverses obesity-induced diacylglycerol accumulation and glucose intolerance","volume":"18","author":"Ruby","year":"2017","journal-title":"Cell Rep"},{"key":"10.1124\/molpharm.121.000357_bib32","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1046\/j.1432-1033.2002.03121.x","article-title":"Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate","volume":"269","author":"Sanghani","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1124\/molpharm.121.000357_bib33","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/dmd.112.045054","article-title":"Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography-tandem mass spectrometry","volume":"40","author":"Sato","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2006.07.001","article-title":"Structure, function and regulation of carboxylesterases","volume":"162","author":"Satoh","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1124\/molpharm.121.000357_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.06.235","article-title":"Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening","volume":"137","author":"Song","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/molpharm.121.000357_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425250903483215","article-title":"Nuclear receptor-mediated regulation of carboxylesterase expression and activity","volume":"6","author":"Staudinger","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/molpharm.121.000357_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/dmd.108.024331","article-title":"Different inhibitory effects in rat and human carboxylesterases","volume":"37","author":"Takahashi","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/molpharm.121.000357_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bfgp\/elw025","article-title":"CRISPR-Cas9 technology: applications and human disease modelling","volume":"16","author":"Torres-Ruiz","year":"2017","journal-title":"Brief Funct Genomics"},{"key":"10.1124\/molpharm.121.000357_bib39","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1124\/molpharm.121.000357_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bcp.2016.03.001","article-title":"Characterization of novel cytochrome P450 2E1 knockout rat model generated by CRISPR\/Cas9","volume":"105","author":"Wang","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/molpharm.121.000357_bib41","first-page":"2605","article-title":"Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan","volume":"8","author":"Xu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1124\/molpharm.121.000357_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijbiomac.2019.04.099","article-title":"A natural inhibitor from Alisma orientale against human carboxylesterase 2: kinetics, circular dichroism spectroscopic analysis, and docking simulation","volume":"133","author":"Yi","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/molpharm.121.000357_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104449","article-title":"Characterization of in vitro Mrp2 transporter model based on intestinal organoids","volume":"108","author":"Zhang","year":"2019","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24011982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.121.000357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:48:29Z","timestamp":1739954909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24011982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0026895X24011982"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.121.000357","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and Characterization of CRISPR\/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.121.000357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}